Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
240 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06259838 | Oral Cavity Squamous Cell Carcinoma and Readmission: Rates, Causes, and Risk Factors. | completed | — | 93 | Abdulsalam AlqutubOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT04991051 | Study to Determine the Prevalence of Homologous Recombination Deficiency Among Women With Newly Diagnosed, High-grade, Serous or Endometrioid Ovarian, Primary Peritoneal, and/or Fallopian Tube Cancer(HALO) | completed | — | 605 | AstraZenecaINDUSTRY |
| 6 |
| Feb 6, 2024 |
| clinicaltrials |
| NCT00565708 | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers(ASCOLT) | unknown | Phase 3 | 1,587 | National Cancer Centre, SingaporeOTHER | 10 | Feb 2, 2024 | clinicaltrials |
| NCT03225586 | Prospective Urban Rural Epidemiology Study(PURE) | recruiting | — | 200,000 | Population Health Research InstituteOTHER | 25 | Jan 31, 2024 | clinicaltrials |
| NCT04836975 | Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:(REVEAL) | completed | — | 45 | AstraZenecaINDUSTRY | 1 | Jan 18, 2024 | clinicaltrials |
| NCT03291899 | Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers(FBI-TRAC) | terminated | Phase 2 | 13 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT00957086 | Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer | unknown | Phase 3 | 710 | National Cancer Centre, SingaporeOTHER | 13 | Jan 9, 2024 | clinicaltrials |
| NCT03674112 | A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer(PHranceSCa) | completed | Phase 2 | 160 | Hoffmann-La RocheINDUSTRY | 17 | Jan 2, 2024 | clinicaltrials |
| NCT06156189 | Prevalence of Enteral Nutrition Interruption in an Oncology Intensive Care Unit. | completed | — | 20 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT02941926 | Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC(COMPLEEMENT-1) | completed | Phase 3 | 3,246 | Novartis PharmaceuticalsINDUSTRY | 38 | Oct 24, 2023 | clinicaltrials |
| NCT05538169 | The Management of RT-induced Hyposalivation Using LLLT(REACH-LLLT) | completed | N/A | 10 | King Saud UniversityOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT04721002 | Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)(MEDICI) | completed | — | 514 | AbbVieINDUSTRY | 22 | Oct 18, 2023 | clinicaltrials |
| NCT06076772 | Palbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients | not yet recruiting | — | 54 | Assiut UniversityOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT06062706 | Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy | unknown | — | 3,448 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Oct 2, 2023 | clinicaltrials |
| NCT03625388 | Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia | completed | Phase 2 | 56 | Hikma Pharmaceuticals LLCINDUSTRY | 4 | Sep 22, 2023 | clinicaltrials |
| NCT04801186 | Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates Cancer(REMPRO) | completed | — | 1,920 | AstraZenecaINDUSTRY | 8 | Sep 7, 2023 | clinicaltrials |
| NCT01242800 | Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer | completed | N/A | 390 | Eastern Cooperative Oncology GroupNETWORK | 5 | Jun 29, 2023 | clinicaltrials |
| NCT05785975 | Effectiveness of Modified Integrated Colorectal Cancer Screening System in Saudi Arabia(ColonCancer) | unknown | N/A | 2,520 | The New Model of Care, Hail Health ClusterOTHER_GOV | 1 | Jun 26, 2023 | clinicaltrials |
| NCT02303444 | An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors(RIFTOS MKI) | completed | — | 667 | BayerINDUSTRY | 19 | Jun 8, 2023 | clinicaltrials |
| NCT03447132 | Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant(SAFIA) | completed | Phase 3 | 354 | International Cancer Research Group, United Arab EmiratesOTHER | 8 | Mar 10, 2023 | clinicaltrials |
| NCT05679817 | How Effective is the Dose-graded Aerobic Training in Children Survivors of Acute Lymphoblastic Leukemia? | completed | N/A | 58 | Cairo UniversityOTHER | 1 | Jan 11, 2023 | clinicaltrials |
| NCT04875793 | Effectiveness of an Integrated Colorectal Cancer Screening in Saudi Arabia: A Pragmatic Randomized Trial(CRCScreen) | completed | N/A | 300 | University of TabukOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT05612269 | SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study | unknown | — | 200 | Ministry of Health, Saudi ArabiaOTHER_GOV | 1 | Nov 10, 2022 | clinicaltrials |
| NCT01414608 | Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer | completed | Phase 3 | 926 | GOG FoundationNETWORK | 5 | Nov 7, 2022 | clinicaltrials |
| NCT04264806 | A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT) | withdrawn | Phase 2 | 0 | Janssen Research & Development, LLCINDUSTRY | 11 | May 20, 2022 | clinicaltrials |
| NCT03940131 | Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR(REPAN) | unknown | Phase 2 | 30 | King Abdullah Medical CityOTHER_GOV | 1 | Apr 6, 2022 | clinicaltrials |
| NCT03957733 | Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients. | unknown | Phase 2 / Phase 3 | 338 | King Abdullah Medical CityOTHER_GOV | 1 | Apr 6, 2022 | clinicaltrials |
| NCT05233683 | Caudal Block Versus Dorsal Penile Nerve Block Plus Ring Block for Pain Management of Different Surgical Techniques of Circumcision in Infants and Children | unknown | Phase 3 | 120 | King Saud UniversityOTHER | 1 | Feb 10, 2022 | clinicaltrials |
| NCT02474355 | Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLC(ASTRIS) | completed | Phase 3 | 3,017 | AstraZenecaINDUSTRY | 16 | Nov 11, 2021 | clinicaltrials |
| NCT01524783 | Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)(RADIANT-4) | completed | Phase 3 | 302 | Novartis PharmaceuticalsINDUSTRY | 25 | Aug 5, 2021 | clinicaltrials |
| NCT04894565 | Physiotherapy Program for Breast Cancer Women Following Surgery: A Pilot Clinical Trial | completed | N/A | 23 | King Fahad Medical CityOTHER_GOV | 1 | May 24, 2021 | clinicaltrials |
| NCT04870502 | Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance | completed | Phase 2 / Phase 3 | 161 | Saudi German Hospital - MadinahOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT01566721 | A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer(SafeHER) | completed | Phase 3 | 2,577 | Hoffmann-La RocheINDUSTRY | 59 | Apr 27, 2021 | clinicaltrials |
| NCT03295006 | A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC(TARGET) | completed | — | 209 | Boston Scientific CorporationINDUSTRY | 8 | Apr 21, 2021 | clinicaltrials |
| NCT04852510 | Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin | completed | Phase 2 / Phase 3 | 253 | Saudi German Hospital - MadinahOTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT00704730 | Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer(EXAM) | completed | Phase 3 | 330 | ExelixisINDUSTRY | 24 | Apr 20, 2021 | clinicaltrials |
| NCT04775862 | A Prospective Study Utilizing Circulating Cell Free DNA (cfDNA) Use in the Detection of RAS Mutations in Patients With Advanced Colorectal Cancer. | unknown | Phase 2 | 60 | National Guard Health AffairsOTHER_GOV | 1 | Mar 1, 2021 | clinicaltrials |
| NCT03452501 | Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients | completed | — | 157 | Hikma Pharmaceuticals LLCINDUSTRY | 1 | Feb 23, 2021 | clinicaltrials |
| NCT04663516 | Effectiveness of Exercise Through Video Games in Reducing Fatigue Among Children With Leukemia | completed | N/A | 46 | King Saud UniversityOTHER | 1 | Feb 10, 2021 | clinicaltrials |
| NCT03014934 | Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation(IPAT) | unknown | — | 2,100 | European Society for Blood and Marrow TransplantationNETWORK | 6 | Jan 14, 2021 | clinicaltrials |
| NCT01572038 | A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer(PERUSE) | completed | Phase 3 | 1,436 | Hoffmann-La RocheINDUSTRY | 39 | Sep 25, 2020 | clinicaltrials |
| NCT02628132 | Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients | completed | Phase 1 / Phase 2 | 22 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT03227068 | Parent Educational Discharge Support Strategies | completed | N/A | 289 | Duke UniversityOTHER | 2 | Jun 30, 2020 | clinicaltrials |
| NCT04377802 | Safe Return to Regular Clinical Operation After COVID-19 Pandemic | unknown | N/A | 400 | King Fahad Specialist Hospital DammamOTHER | 1 | May 6, 2020 | clinicaltrials |
| NCT04344847 | Incidental Finding of Gastrointestinal Stromal Tumors (GISTs) During Laparoscopic Sleeve Gastrectomy, How to Deal? How Much Safety Margin | unknown | N/A | 338 | Bassem Mohamed SiedaOTHER_GOV | 1 | Apr 14, 2020 | clinicaltrials |
| NCT03778099 | The Effect of Cinnamon on Ovulation Induction in Women With Polycystic Ovary Syndrome(PCOS) | completed | Phase 3 | 33 | King Abdulaziz UniversityOTHER | 1 | Mar 3, 2020 | clinicaltrials |
| NCT04235179 | Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer(ASPIRE) | unknown | Phase 2 | 30 | King Saud UniversityOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT04212715 | Prostate SABR With Intra-Prostatic SABR Boost | recruiting | Phase 2 | 30 | King Saud UniversityOTHER | 1 | Jan 2, 2020 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials